Entering text into the input field will update the search result below

Cannabics files a PCT patent application for proprietary cancer treatment formulations

  • Cannabics Pharmaceuticals (OTCQB:CNBX) announces that it has filed a patent application under the Patent Cooperation Treaty (PCT) for novel formulations developed for treatment of various cancer types.
  • The patent application includes preclinical supporting data collected from in-vitro experiments performed in the

Recommended For You

More Trending News

About CNBX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CNBX--
CNBX Pharmaceuticals Inc.